Therapies

AveXis Inc.: Research Associate III

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

A novel role of tumor suppressor ZMYND8 in inducing differentiation of breast cancer cells through its dual-histone binding function

1 day ago | Journal of Biosciences | 2 articles

Abstract Accumulating evidences indicate the involvement of epigenetic deregulations in cancer. While some epigenetic regulators with aberrant functions in cancer are targeted...
Read more ...

AveXis Inc.: Senior Scientist, Molecular Biology

1 day ago | San Diego Biotechnology

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

Revolution Medicines Maps Out an IPO to Reach Cancer's Frontiers

2 days ago | Xconomy

Cancer research has revealed proteins known to play a role in the disease, but with no known way of stopping what they do. In pharmaceutical parlance, they're “undruggable.”...
Read more ...

After IPO, BioNTech nabs cell therapy startup Neon Therapeutics

3 days ago | Fierce Biotech

There's been a deal at the annual J.P. Morgan Healthcare Conference in San Francisco, but probably not with the largest names and certainly not big bucks.
Read more ...

AveXis Inc.: Senior Scientist, In Vivo

3 days ago | San Diego Biotechnology

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative

4 days ago | Xconomy

The Department of Defense has awarded Adaptive Phage Therapeutics a $10.2 million contract to help advance its experimental therapy for the treatment of multidrug-resistant...
Read more ...

Astellas teams with Adaptimmune to create CAR-T, TCR therapies

5 days ago | Fierce Biotech

Astellas has teamed up with Adaptimmune to develop allogeneic chimeric antigen receptor T-cell and T-cell receptor therapies. The agreement sees Astellas pay $50 million...
Read more ...

Angiocrine Bioscience, Inc.: Exec. Dir/V.P. - Medical & Clinical Development, Regenerative Medicine and Gene Therapy

6 days ago | San Diego Biotechnology

Angiocrine Bioscience, Inc.: Serve as medical leader for our RM & GT programs to transform medicine through cellular therapies that restore, regenerate and repair tissues. San...
Read more ...

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

6 days ago | Xconomy

JP Morgan's annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among the discussion topics...
Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Interfacial molecular interactions of cellobiohydrolase Cel7A and its...

Molecular-scale mechanisms of the enzymatic breakdown of cellulosic biomass into fermentable sugars are still poorly understood, with a need for independent measurements of... Read more ...

Brassinosteroid overproduction improves lignocellulose quantity and quality...

As a leading biomass feedstock, poplar plants provide enormous lignocellulose resource convertible for biofuels and bio-chemicals. However, lignocellulose recalcitrance... Read more ...

US biofuel production and policy: implications for land use changes in...

It has been argued that the US biofuel policy is responsible for the land use changes in Malaysia and Indonesia. In this paper, following a short literature review that... Read more ...

Programmable nests for cells

Using DNA, smallest silica particles, and carbon nanotubes, researchers developed novel programmable materials. These nanocomposites can be tailored to various applications and... Read more ...

AveXis Inc.: Research Associate III

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Mirati Therapeutics: Student Assistant

Mirati Therapeutics: Mirati Therapeutics is a targeted oncology company developing an advanced pipeline of breakthrough medicines for precisely defined patient populations San... Read more ...

Inhibition of lignification of Zizania latifolia with radio frequency...

Zizania latifolia is easily lignified after harvesting, leading to the degradation of food quality and commercial value. Thus, this study evaluated the effect of radio... Read more ...

Performance difference of graph-based and alignment-based hybrid error...

The error-prone third-generation sequencing long reads can be corrected by the high-quality second-generation sequencing short reads, which is referred to as hybrid error... Read more ...

CHROMATIX: computing the functional landscape of many-body chromatin...

Chromatin interactions are important for gene regulation and cellular specialization. Emerging evidence suggests many-body spatial interactions play important roles in... Read more ...

Bachem: Validation Engineer II, QA

Bachem: Your Responsibilities The Validation Engineer II fulfills a critical role in GMP operations. This individual must plan and execute validation studies, Vista, CA, US ... Read more ...